Dave Ricks

Former US Vice President Al Gore discusses the accelerating climate crisis, the global energy transition and the economic case for renewables in a wide-ranging conversation with David Rubenstein at the World Economic Forum in Davos. Gore reflects on extreme weather events, climat ...  Show more

World-renowned celebrity makeup artist, entrepreneur and author Bobbi Brown discusses her journey from selling lipsticks out of her garage to selling her company to Estee Lauder in 1995 - a deal that included a 25-year non-compete. She also talks about the evolution of the cosmet ...  Show more

Benjamin Y. Fong is author of the new book Quick Fixes: Drugs in America from Prohibition to the 21st Century Binge, which was just released in July, 2023 by Verso Books. Ben is an honors faculty fellow and associate director of the Center for Work & Democracy at Arizona State Un ...  Show more

Carl Quintanilla and Jim Cramer led off the show by delving into the broadening market rally, as the S&P 500 and Nasdaq aim for a ninth consecutive day of gains. David Faber called into the show with reporting on Edgar Bronfman's bid to acquire Paramount Global. Eli Lilly CEO ...

Karen Andersen, biotechnology strategist for Morningstar Research Services, discusses what GLP-1 drugs’ demand means for the biopharma industry’s five-year outlook. And whether the weight-loss drugs pose a threat to snack food stocks.

Why GLP-1 Drugs Are in Demand 

We've curated a special 10-minute version of the podcast for those in a hurry.   Here you can listen to the full episode:  https://podcasts.apple.com/no/podcast/eli-lilly-ceo-the-weight-loss-drug-revolution-ai-in/id1614211565?i=1000693848152&l=nb Nicolai Tangen meets with David Ri ...  Show more